XtalPi and Gan & Lee Pharmaceuticals Partner to Advance AI-Driven Peptide Drug Discovery for Metabolic Diseases

XtalPi Wins First Prize at National “Data Element ×” Competition Finals

XtalPi’s AI Platform Cracks Hair Loss Challenge with Breakthrough “Twin-Star” Molecular Formula

XtalPi Added to MSCI China Index, Recognized as Global Investment Benchmark for Growth Potential

XtalPi Subsidiary Ailux Seals $345M AI-Powered Bispecific Antibody Partnership with Eli Lilly

XtalPi and Baicheng Medicine Announce Strategic Collaboration to Advance Innovative Drug Development

XtalPi Leadership Visits China Merchants Group to Explore Strategic Collaboration in AI-Driven Innovation

XtalPi Announces Milestone Achievement in Collaboration with PharmaEngine on Next-Generation PRMT5 Inhibitor PEP08

Signet Therapeutics, Incubated by XtalPi, Nominated for 2025 Prix Galien USA Best Biotechnology Award for First-in-Class Diffuse Gastric Cancer Drug SIGX1094R

XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies

XtalPi and DoveTree Announce Landmark $6 Billion AI Drug Discovery Collaboration

XtalPi Innovation Center and JingJiaHang BioPharma Announce Strategic Collaboration to Advance AI-Driven Radionuclide Drug Development